News
-
-
COMMUNIQUÉ DE PRESSE
Leading Independent Proxy Advisory Firm ISS Recommends Think Research Corporation Shareholders Approve The Arrangement With Beedie Capital
Think Research Corporation announces ISS recommendation for Beedie Capital transaction. Shareholders urged to vote in favor. Details of the acquisition and Meeting provided -
-
COMMUNIQUÉ DE PRESSE
Think Research's Pharmapod Adopted in University and Colleges Across Canada to Teach Foundations of Medication Safety
Think Research Corporation announces Pharmapod, their medication incident management solution, is increasingly being integrated into academic programs across Canada, equipping students with essential skills for healthcare. Pharmapod enhances medication safety and quality care -
-
COMMUNIQUÉ DE PRESSE
Think Research Announces a $5.0 Million Contract Expansion with a Global Pharmaceutical Company
Think Research Corporation expands contract with global pharmaceutical client, adding $5.0 million agreement for Learning Management System and SaaS license. Total contract value reaches $15.0 million since May 2022 -
-
-
COMMUNIQUÉ DE PRESSE
Think Research Enters into Definitive Agreement to be Acquired by Beedie Capital
Think Research Corporation announces Beedie Investments Ltd. will acquire all common shares for $0.32 per Share in a strategic Transaction offering immediate liquidity to stakeholders and a significant premium. Special Committee and Board unanimously support the deal -
COMMUNIQUÉ DE PRESSE
Think Research Announces Agreement for Subsequent Advance Under Existing Convertible Facility
Think Research Corporation (TSXV:THNK) has announced the entry into an agreement for a $1 million convertible subsequent advance from Beedie Investments Ltd. The proceeds will be used for general and working capital purposes. The company intends to use the advance to support its mission of delivering knowledge-based digital health software solutions and organize the world's health knowledge. The advance forms part of the $25 million convertible facility with Beedie Capital previously announced on April 25, 2022.
